Oxaceprol
Oxaceprol is an established therapeutic agent for osteoarthritis. (In Vitro) :Oxaceprol, at 6 mg/kg/day for 7 days, significantly reduces both the surface area and wet weight of cotton pellet granulomas, being slightly less effective than indomethacin, 3 mg/kg.Oxaceprol (6–54 mg/kg/day) given therapeutically had no effect on the primary paw oedema response, but inhibits secondary lesions in the ears and tail.Oxaceprol does not inhibit the synthesis of prostaglandins in vitro, but markedly inhibits neutrophil infiltration into the joints of rats with adjuvant arthritis.
Product Specifications
CAS Number
33996-33-7
Product Name Alternative
N-Acetyl-L-hydroxyproline
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO:1 mg/mL (577.47 mM)
Smiles
CC (=O) N1C[C@@H] (C[C@H]1C (=O) O) O
Molecular Formula
C7H11NO4
Molecular Weight
173.17
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(2S4R) -1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bovine dicer 1, ribonuclease type III ELISA Kit
PRMT1, CT (Protein Arginine N-Methyltransferase 1, Interferon Receptor 1-bound Protein 4, HMT2, HRMT1L2, IR1B4) discontinued
